ANGELA FINNEY: Open Payments
NPI 1326004011 · BARTLESVILLE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 20 payments from 7 companies in 2025. Trend: 2023 $70 · 2024 $414 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $179 |
| ABIOMED | 3 | $98 |
| Amgen Inc. | 2 | $34 |
| Innovation Technologies Inc | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
Products named: LEQVIO, REPATHA, IRRISEPT, ONPATTRO, Kerendia, FUROSCIX.
Industry payments across OK — which companies pay providers there.
